Search Results - "Kaura, S."

Optimal Timing of Alveolar Cleft Bone Grafting for Maxillary Clefts in the Cleft Palate Population by Kaura, Arminder S, Srinivasa, Dhivya R, Kasten, Steven J

“…Timing of bone grafting for maxillary alveolar clefts is not standardized. Secondary bone grafting is often performed; however, consensus does not exist…”
Get full text

Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial by Lindley, R I, Anderson, C S, Billot, L, Forster, A, Hackett, M L, Harvey, L A, Jan, S, Li, Q, Liu, H, Langhorne, P, Maulik, P K, Murthy, G V S, Walker, M F, Pandian, J D, Alim, M, Felix, C, Syrigapu, A, Tugnawat, D K, Verma, S J, Shamanna, B R, Hankey, G, Thrift, A, Bernhardt, J, Mehndiratta, M M, Jeyaseelan, L, Donnelly, P, Byrne, D, Steley, S, Santhosh, V, Chilappagari, S, Mysore, J, Roy, J, Padma, M V, John, L, Aaron, S, Borah, N C, Vijaya, P, Kaul, S, Khurana, D, Sylaja, P N, Halprashanth, D S, Madhusudhan, B K, Nambiar, V, Sureshbabu, S, Khanna, M C, Narang, G S, Chakraborty, D, Chakraborty, S S, Biswas, B, Kaura, S, Koundal, H, Singh, P, Andrias, A, Thambu, D S, Ramya, I, George, J, Prabhakar, A T, Kirubakaran, P, Anbalagan, P, Ghose, M, Bordoloi, K, Gohain, P, Reddy, N M, Reddy, K V, Rao, T N M, Alladi, S, Jalapu, V R R, Manchireddy, K, Rajan, A, Mehta, S, Katoch, C, Das, B, Jangir, A, Kaur, T, Sreedharan, S, Sivasambath, S, Dinesh, S, Shibi, B S, Thangaraj, A, Karunanithi, A, Sulaiman, S M S, Dehingia, K, Das, K, Nandini, C, Thomas, N J, Dhanya, T S, Thomas, N, Krishna, R, Aneesh, V, Khullar, S, Thouman, S, Sebastian, I

“…Most people with stroke in India have no access to organised rehabilitation services. The effectiveness of training family members to provide stroke…”
Get full text

Time best served by Kaura, S.

Get full text

A Prospective Time and Motion Analysis Comparing Intravenous (IV) Vesus Subcutaneous (SC) Bortezomib in Patients with Multiple Myeloma (MM) by Dranitsaris, G, Kaura, S

Get full text

Valuing Survival Gains In Myelodysplastic Syndromes Attributable To Novel Cancer Therapies by MacEwan, J.P, Yin, W, Khan, Z.M, Kaura, S

Get full text

PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Comparative Effectiveness Analysis Using Indirect Statistical Techniques by Kaura, S, Dranitsaris, G

Get full text

PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Number Needed to Treat (NNT) Analysis by Kaura, S, Dranitsaris, G

Get full text

PCN16 Comparison of the Efficacy and Cost of Novel Targeted Cancer Therapies by Kaura, S, Khan, Z

Get full text

3602 POSTER The Number Needed to Treat (NNT) as a Measure of Incremental Drug Benefit: Denosumab Vs. Zoledronic Acid for the Prevention of Skeletal Related Events (SREs) in Castration-Resistant Prostate Cancer (CRPC) by Dranitsaris, G, Kaura, S

Get full text

3603 POSTER The Number Needed to Treat (NNT) as a Measure of Incremental Drug Benefit: Denosumab Vs. Zoledronic Acid for the Prevention of Skeletal Related Events (SREs) in Patients With Other Solid Tumours or Multiple Myeloma by Dranitsaris, G, Kaura, S

Get full text

Literature review of the use of ICER thresholds in Healthcare decision-making by Kaura, S, Nanavaty, M, Seetasith, A, Nyandege, A, Khan, Z.M

Get full text

PCN83 Novel Targeted Drug Therapies in the Cancer Setting: A Descriptive Comparison of Efficacy and Cost by Dranitsaris, G, Kaura, S

Get full text

A Survey of ispor attendee views on the use of ICER and acceptable ICER thresholds by Kaura, S, Seetasith, A, Ramesh, V, Nanavaty, M, Proach, J, Khan, Z.M

Get full text

Systematic Literature Review Of Compliance And Persistence Programs In Inflammation And Immunology by Burudpakdee, C, Kaura, S, Gala, S, Nanavaty, M, Khan, Z.M

Get full text

Impact of Patient Programs On Adherence In Inflammation and Immunology: A Global Systematic Review and Meta-Analysis of Published Evidence by Burudpakdee, C, Khan, Z.M, Gala, S, Nanavaty, M, Kaura, S

Get full text

Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc): A Cost Utility Analysis from a Chinese Health Care Perspective by Dranitsaris, G, Yu, B, Qing, Z, King, J, Zhang, A, Kaura, S

Get full text

PCN11 The Impact of Treatment Persistence With Lenalidomide (LEN) for the Treatment of Multiple Myeloma (MM) on Disease Control by Henk, H, Kaura, S, Khan, Z, Teitelbaum, A

Get full text

P285 A clinical comparison of letrozole or anastrozole for the treatment of hormone-positive breast cancer using indirect statistical techniques by Dranitsaris, G, Kaura, S

Get full text

Progressive innovation in oncology: Valuing outcomes beyond survival by Quinn, C, Palmer, S, Bruns, J, Borras, J.M, Grant, C, Sykes, D, Kaura, S

Get full text

Impact of Novel Therapies on Multiple Myeloma Survival– Current and Future Outcomes by Drawid, A, Kaura, S, Kiely, D, Hussein, M.A, Kaman, M, Gilra, N, Durie, B.G.M

Get full text